Bairey CN, Shah PK, Lew AS, Hulse S Electrocardiographic differentiation of occlusion of the left circumflex versus the right coronary artery as a cause of inferior acute myocardial infarction. Am J Cardiol. 1987 Sep 1;60(7):456-9.
Bayram E, Atalay C Identification of the culprit artery involved in inferior wall acute myocardial infarction using electrocardiographic criteria. J Int Med Res. 2004 Jan-Feb;32(1):39-44.
Braat SH, de Zwaan C, Brugada P, Coenegracht JM, Wellens HJ Right ventricular involvement with acute inferior wall myocardial infarction identifies high risk of developing atrioventricular nodal conduction disturbances. Am Heart J. 1984 Jun;107(6):1183-7.
Chia BL, Yip JW, Tan HC, Lim YT Usefulness of ST elevation II/III ratio and ST deviation in lead I for identifying the culprit artery in inferior wall acute myocardial infarction. Am J Cardiol. 2000 Aug 1;86(3):341-3.
Hamon M, Agostini D, Le Page O, Riddell JW, Hamon M Prognostic impact of right ventricular involvement in patients with acute myocardial infarction: meta-analysis. Crit Care Med. 2008 Jul;36(7):2023-33. doi: 10.1097/CCM.0b013e31817d213d. Review.
Hasdai D, Birnbaum Y, Herz I, Sclarovsky S, Mazur A, Solodky A ST segment depression in lateral limb leads in inferior wall acute myocardial infarction. Implications regarding the culprit artery and the site of obstruction. Eur Heart J. 1995 Nov;16(11):1549-53.
Herz I, Assali AR, Adler Y, Solodky A, Sclarovsky S New electrocardiographic criteria for predicting either the right or left circumflex artery as the culprit coronary artery in inferior wall acute myocardial infarction. Am J Cardiol. 1997 Nov 15;80(10):1343-5.
Huey BL, Beller GA, Kaiser DL, Gibson RS A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol. 1988 Nov;12(5):1156-66.
Kontos MC, Desai PV, Jesse RL, Ornato JP Usefulness of the admission electrocardiogram for identifying the infarct-related artery in inferior wall acute myocardial infarction. Am J Cardiol. 1997 Jan 15;79(2):182-4.
Nair R, Glancy DL ECG discrimination between right and left circumflex coronary arterial occlusion in patients with acute inferior myocardial infarction: value of old criteria and use of lead aVR. Chest. 2002 Jul;122(1):134-9.
Witters PG, Cools FJ Evaluation of electrocardiographic algorithms in the assessment of the infarct-related artery in acute myocardial infarction. Acta Cardiol. 2006 Aug;61(4):446-53.
Wong TW, Huang XH, Liu W, Ng K, Ng KS New electrocardiographic criteria for identifying the culprit artery in inferior wall acute myocardial infarction-usefulness of T-wave amplitude ratio in leads II/III and T-wave polarity in the right V5 lead. Am J Cardiol. 2004 Nov 1;94(9):1168-71.
Zimetbaum PJ, Josephson ME Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 2003 Mar 6;348(10):933-40. Review.
Electrocardigram Identifying the Culprit Site in Patients With Acute Inferior Myocardial Infarction
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
